The regulatory file for L-lysine free base
L-lysine free base is the amino acid CAS 56-87-1, sold as a food ingredient. The specification and COA describe the material; the market route, the ingredient name and the claim review are separate. In the EU, amino acids do not follow the harmonised vitamin-and-mineral route; in the US, L-lysine is a dietary ingredient. The buyer's regulatory team confirms the finished-product position.
The file has to show the free base by name and CAS, and the label has to name the same form the specification describes.
What the file holds
The file has four parts: the current specification, the lot certificate, the destination rules and the change record. The COA covers the lot, the TDS states the specification, the SDS covers handling, and none of them decides the market route. The form is the first checkpoint: the base has no chloride and an alkaline solution, while the salt has 19.0–19.6% chloride and a 5% solution at pH 5.0–6.0. A file that mixes the two is inconsistent before any regulator sees it. Name the form and CAS in the specification, the COA, the label text and the quotation.
European Union
L-lysine has a long history in food, but the novel-food status of the exact form and use should still be checked against the Commission's catalogue as of this review. Directive 2002/46/EC harmonises vitamins and minerals, not amino acids, so member-state rules and mutual recognition generally decide the route. The buyer's team fixes the member-state position and checks the material as placed on the market.
Labelling follows Regulation (EU) No 1169/2011: the ingredient list names the ingredient used. The free base is “L-lysine”; the salt is “L-lysine hydrochloride”. A quantitative statement should say whether the number refers to the base, the salt or the lysine entity. Claims are separate under Regulation (EC) No 1924/2006, and the current consolidated text is the reference.
United States
L-lysine is a dietary ingredient under DSHEA. Supplement Facts lists “L-lysine”; when the salt is used, the lysine entry carries “(as L-lysine hydrochloride)” and the quantity declared is lysine. Lysine has no Daily Value, so the panel shows no percentage. A structure/function statement rests on substantiation and the DSHEA disclaimer; label and claim review sit outside the COA.
Contaminants and limits
Contaminant limits are calculated for the finished product, not only measured on the drum. The table is a starting point for a supplement file; the current text for the destination and the daily dose fix the final figure. In the EU, Regulation (EU) 2023/915 sets maximum levels for lead, cadmium and mercury in food supplements; arsenic is not harmonised at EU level as of this review.
| Metal | Reference level | Evidence to hold |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the finished supplement | Result, method and the dose calculation |
| Cadmium (Cd) | 1.0 mg/kg in the finished supplement | Result plus any category exception |
| Mercury (Hg) | 0.10 mg/kg in the finished supplement | Result and method |
| Arsenic (As) | Market or customer limit | Agreed limit and method, on the certificate |
The catalog limits are Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. They apply to the ingredient; the finished-product calculation has to account for the dose and for the other ingredients in the formula.
Claims and the label boundary
In the EU, no authorised health claim for lysine is listed in the Register as of this review. A claim written for another amino acid does not transfer, and a disease-related claim is outside the regulation. In the US, a structure/function statement needs supporting evidence and the DSHEA disclaimer, and it cannot be a disease claim. No health claim is made here.
The form is part of the claim file. A label that says “L-lysine” while the drum is the hydrochloride would declare 500 mg of lysine from 500 mg of salt, which delivers about 400 mg. A label that names the salt has to be consistent with the chloride and pH data behind it. Review the label and the specification together, not in two separate rounds.
Documents for the free-base file
The buyer should hold a COA showing the titration, the rotation and its conditions, IR identification, loss on drying, particle size, the metal panel and the micro count. Add the specification version, the TDS, the SDS, the allergen and GMO statements, the origin record, the residual-solvent statement and the novel-food status. Chloride is not routine for the base, but it is the test that separates the form when the certificate is silent.
The COA should name the free base and the assay basis. An as-is figure, a dried-basis figure and a salt figure are three different numbers. The buyer owns the market route, the finished dose and the label review; the supplier owns the source, the process and the pack record.
Checklist before the first order
- The specification version, CAS 56-87-1 and the free-base name are on the sheet.
- COA, TDS, SDS, allergen, GMO, origin and solvent statements sit in the folder.
- Contaminant figures are recalculated for the daily dose.
- Label, quantity statement and claim have been checked for the destination.
- Source, process and pack changes have an owner and a record.
- Quotation, specification and certificate share one version.
The catalog specification is on the product hub. The other form is on the hydrochloride page. The lot certificate is explained on the COA page; the evidence is on the identity page; release is described on the quality page; the tests are in the methods library.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation